tiprankstipranks
RBC ‘not altogether surprised’ by Sage move lower after failure in PD
PremiumThe FlyRBC ‘not altogether surprised’ by Sage move lower after failure in PD
8d ago
Sage Therapeutics cut to Underperform at BofA after Parkinson’s trial fails
PremiumThe Fly
Sage Therapeutics cut to Underperform at BofA after Parkinson’s trial fails
8d ago
Sage Therapeutics downgraded to Underperform from Neutral at BofA
PremiumThe Fly
Sage Therapeutics downgraded to Underperform from Neutral at BofA
8d ago
SAGE Therapeutics Board Member Announces Retirement
PremiumCompany AnnouncementsSAGE Therapeutics Board Member Announces Retirement
1M ago
Sage Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Sage Therapeutics management to meet with Piper Sandler
1M ago
Sage Therapeutics price target raised to $29 from $24 at JPMorgan
PremiumThe Fly
Sage Therapeutics price target raised to $29 from $24 at JPMorgan
1M ago
Sage Therapeutics price target raised to $26 from $21 at RBC Capital
PremiumThe FlySage Therapeutics price target raised to $26 from $21 at RBC Capital
2M ago
Sage Therapeutics price target raised to $25 from $23 at Oppenheimer
PremiumThe Fly
Sage Therapeutics price target raised to $25 from $23 at Oppenheimer
2M ago
Bad News for SAGE Therapeutics, Inc. (US) Stock: This New Risk Has Been Added
PremiumMarket News
Bad News for SAGE Therapeutics, Inc. (US) Stock: This New Risk Has Been Added
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100